Sachin S. Mali

Dr. Sachin S. Mali

Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, Kolhāpur, India
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SRSanket Rathod
Sanket Rathod
SDSreenath Dey
Sreenath Dey
SPSwaranjali Pawar
Swaranjali Pawar
RDRakesh Dhavale
Rakesh Dhavale
PCPrafulla Choudhari
Prafulla Choudhari
HMHarinath More
Harinath More
The cases of bacterial multidrug resistance are increasing every year and becoming a serious concern for human health. Multidrug efflux pumps are key players in the formation of antibiotic resistance, which transfer out a broad spectrum of drugs from the cell and convey resistance to the host. Efflux pumps have significantly reduced the efficacy of the previously available antibiotic armory, thereby increasing the frequency of therapeutic failures. In gram-negative bacteria, the AcrAB-TolC efflux pump is the principal transporter of the substrate and plays a major role in the formation of antibiotic resistance. In the current work, advanced computer-aided drug discovery approaches were utilized to find hit molecules from the library of biogenic chalcones against the bacterial AcrB efflux pump. The results of the performed computational studies via molecular docking, drug-likeness prediction, pharmacokinetic profiling, pharmacophore mapping, density functional theory, and molecular dynamics simulation study provided ZINC000004695648, ZINC000014762506, ZINC000014762510, ZINC000095099506, and ZINC000085510993 as stable hit molecules against the AcrB efflux pumps. Identified hits could successfully act against AcrB efflux pumps after optimization as lead molecules.Communicated by Ramaswamy H. Sarma.
1

25 June 2025 in The Open Medicinal Chemistry Journal
Verified
Journal Article
Open access
PDF file
TKTejashree Khamkar
Tejashree Khamkar
RKRushikesh Kadam
Rushikesh Kadam
Sachin S. MaliSachin S. Mali
Sachin S. Mali
BUBabaso Udugade
Babaso Udugade
Sudarshan SinghSudarshan Singh
Sudarshan Singh
1,3,4-Oxadiazoles are a vital class of nitrogen-containing five-membered heterocycles that have drawn considerable attention due to their diverse pharmacological properties. These compounds exhibit a broad spectrum of biological activities, including anticancer, antibacterial, anti-inflammatory, anti-HIV, anti-tubercular, anti-diabetic, and antifungal effects. Their unique structural framework makes them highly valuable in drug discovery and medicinal chemistry. This review provides a comprehensive overview of the various synthetic strategies employed to develop 1,3,4-oxadiazole derivatives. Both conventional and advanced methods are discussed in detail, including the cyclization of hydrazides, oxidative cyclization, and environmentally friendly green chemistry approaches. Additionally, we highlight how structural modifications influence their bioactivity, paving the way for the design of more potent therapeutic agents. Beyond synthesis, this paper explores the pharmacological evaluation of 1,3,4-oxadiazoles through various biological assays. The relationship between molecular structure and biological activity is examined, offering valuable insights into the rational design of novel derivatives with enhanced efficacy and selectivity. Given their versatility as a privileged scaffold in medicinal chemistry, 1,3,4-oxadiazoles hold significant promise in the development of new treatments for various diseases. Overall, this review serves as a valuable resource for researchers interested in the synthesis and therapeutic potential of 1,3,4-oxadiazole derivatives, aiding in the development of innovative drugs with improved pharmacological properties.

1 January 2015 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PDF file
AAAmita A. Ahir
Amita A. Ahir
Sachin S. MaliSachin S. Mali
Sachin S. Mali
AHAshok A. Hajare
Ashok A. Hajare
Durgacharan Arun BhagwatDurgacharan Arun Bhagwat
Durgacharan Arun Bhagwat
PPPrasad V. Patrekar
Prasad V. Patrekar
Pellets are small free flowing; spherical particulates manufactured by the agglomeration of fine powder or granules. Different types of techniques used to produce pellets are referred to as pelletization techniques. In relation to pharmaceuticals, pellets offer high degree of flexibility in design and development of oral dosage form. They offer desired dose strength, can be blended to deliver incompatible bioactive agents and can be blended to provide different release profiles. The most commonly use pelletization processes are Extrusion spheronization, Hot melt extrusion, Solution or suspension layering, Powder layering, High shear pelletization, Freeze pelletization, Cryopelletization, Crystallo-co-agglomeration, Wet spherical agglomeration, Spherical crystallization etc. In present review we will be explaining widely used pelletization techniques especially are Extrusion Spheronization and Hot Melt Extrusion in detail with methods and applications in pharmaceutical industries because these techniques represent an efficient pathway for novel drug delivery system today.
1

22 December 2025 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
PPPuja B. Pujari
Puja B. Pujari
DSDr. Anilkumar Shinde
Dr. Anilkumar Shinde
ASAbhijeet C. Shedmake
Abhijeet C. Shedmake
AJAnbhule Sachin Jalindar
Anbhule Sachin Jalindar
Sachin S. MaliSachin S. Mali
Sachin S. Mali
Sudarshan SinghSudarshan Singh
Sudarshan Singh

15 January 2015 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
SDSujata D. Dongare
Sujata D. Dongare
Sachin S. MaliSachin S. Mali
Sachin S. Mali
PPPrasad V. Patrekar
Prasad V. Patrekar

23 June 2025 in Food and Humanity
Verified
Journal Article
Closed access
Sachin S. MaliSachin S. Mali
Sachin S. Mali
DIPAK S THORATDIPAK S THORAT
DIPAK S THORAT
Sudarshan SinghSudarshan Singh
Sudarshan Singh
YUYogesh V. Ushir
Yogesh V. Ushir
PPPrajakta R. Patil
Prajakta R. Patil
AKAkshay Kundale
Akshay Kundale